1986
DOI: 10.2337/diab.35.6.662
|View full text |Cite
|
Sign up to set email alerts
|

In Vivo Regulation of Liver and Skeletal Muscle Glycogen Synthase Activity by Glucose and Insulin

Abstract: The regulation of liver and skeletal muscle glycogen synthase by plasma insulin and glucose has not been investigated in vivo at physiological blood glucose concentrations. We have, therefore, used the glucose clamp technique to investigate the effects of these variables independently in rats. Short-term streptozocin-(0.15 g/kg) diabetic animals were used in addition to normal rats to avoid endogenous insulin secretion during hyperglycemic clamps. In normal and diabetic animals, 3 h of hyperinsulinemia without… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
18
0

Year Published

1987
1987
2018
2018

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 53 publications
(21 citation statements)
references
References 0 publications
3
18
0
Order By: Relevance
“…5; r = 0.89, p < 0.001) in the cirrhotic patients suggests they can achieve peripheral insulin levels in response to intravenous glucose that, despite their insulin insensitivity, result in a glucose disposal rate appropriate to the prevailing blood glucose level. The strong relationship between the peripheral insulin concentration and clamp glucose disposal is consistent with the observation that -under glucose clamp conditions with peripheral venous glucose administrationvery little glucose is taken up by liver, skeletal muscle being the major determinant of whole-body glucose disposal (38)(39)(40).…”
Section: Discussionsupporting
confidence: 85%
See 1 more Smart Citation
“…5; r = 0.89, p < 0.001) in the cirrhotic patients suggests they can achieve peripheral insulin levels in response to intravenous glucose that, despite their insulin insensitivity, result in a glucose disposal rate appropriate to the prevailing blood glucose level. The strong relationship between the peripheral insulin concentration and clamp glucose disposal is consistent with the observation that -under glucose clamp conditions with peripheral venous glucose administrationvery little glucose is taken up by liver, skeletal muscle being the major determinant of whole-body glucose disposal (38)(39)(40).…”
Section: Discussionsupporting
confidence: 85%
“…Insulin sensitivity in our subjects was measured by the euglycemic clamp technique using an insulin infusion rate considerably higher than that shown to suppress hepatic glucose production completely in both cirrhotic patients and controls (6,17). Because only a small fraction of the infused glucose is taken up by liver (38)(39)(40), the lower glucose requirement during the euglycemic clamp (Fig. 2) implies marked peripheral tissue insulin resistance in our patients.…”
Section: Discussionmentioning
confidence: 87%
“…It may be speculated that under these conditions insulin-controlled metabolic processes in muscle which are connected to alanine production are altered on the basis of the chronically elevated insulin action which is more or less reversed by portal insulin administration. An elevated peripheral insulin action would stimulate the muscular uptake of glucose [25,26], thereby feeding glycogen synthesis and glycolysis. Thus, lactate becomes the main product of glucose utilisation, even in resting muscle; this can be seen from the high circulating lactate levels.…”
Section: Discussionmentioning
confidence: 99%
“…Under these conditions, VLDLtriglyceride turnover fell by 20-30% in both normal and insulin over-treated rats, and at the end of the clamp was significantly less in the chronically insulin over-treated group (Table 2). Since, in the insulin overtreated animals, glucose requirement during the clamp was decreased, and as only a small proportion of infused glucose is stored as glycogen in the rat [29], a decreased supply of 3-carbon intermediates (lactate, pyruvate, alanine) for hepatic de novo lipogenesis might appear to be the important determinant of VLDL production as in the fasting state. Insulin insensitivity in the lipogenic pathway within the liver cannot, however, be ruled out.…”
Section: Discussionmentioning
confidence: 99%